EFTA02007381

To: jeeyacation©gmail.com[jeeyacationetgmail.com]; Jeffrey Epsteinbeevacation©gmail corn] From: Jeffrey Epstein Sent Mon 4/15/2013 6:51:16 PM Subject: Fwd: Press Article attached Hi Jeffrey, I sent the press links to Dr. Ting. See below. Forwarded message From: Ting, Jess a Date: Mon, Apr 15, 2013 at 12:50 PM Subject: Re: Press Article attached To: Jeffrey Epstein leffreyepsteinorgragmail.com> Wonderful! Jess Ting On Apr 15, 2013, at 12:49 PM, "Jeffrey Epstein" [email protected]<mailto:[email protected]>> wrote: Dear Dr. Ting, Below are some press links for you. The article was also picked up by the Wall Street Journal Market Watch, Boston Globe etc. Thank you so much and I look forward to collaborating down the road! best regards, CBS Moneywatch http://markets.cbsnews.com/cbsnews/news/read/23924625/Jeffrey Epstein Reuters http://pdfreuters.com/pdfnews/pdfnews.asp?i=43059c3bf0e375418cu=unEnewsml:reuters.com On Jess wrote: I would eliminate DNA transcription factors. These would not be present in wound fluid. Jess Ting On Apr 12, 2013, at 1:24 PM, "Jeffrey Epstein" [email protected]:[email protected]><mailto:jeffreyepsteinorg@ gmail.conailto:jeffityepsteinorgagmail.com>>> wrote: Dear Dr. Tess, Thank you for your clarification. Please see the edited press release and let me know if it is okay for me to send out. I will send you some of the press links when published. my best regards, EFTA_R1_00507257 EFTA02007381 On Thu, Apr 11, 2013 at 4:52 PM, Ting, Jess [email protected]<[email protected]><mailto:jess.tingamountsinai.ore< mailto:[email protected]>>> wrote: The goal is not to improve vigilance or early surgery but to detect those who, AFTER surgery, are at higher risk for metastases. If we could develop a diagnostic test based on our research findings, it could be used to strati& patients based on the risk of metastasis. Jess Ting On Apr 11, 2013, at 3:12 PM, "Jeffrey Epstein" <jeffreyepsteinorg@,gmail.com<mailto:jeffreyepsteinorgRgmail.com><mailto:jeffreyegsteinorg@ gmail.com<mailto:[email protected]>><mailto:jeffreyepsteinorg©gmail.com<mailtoj effreyepsteinorg©gmail.com><mailto:jeffrejepsteinorg©gmail.com<mailto:jeffreyepsteinorgag mail.com>>>> wrote: Dear Dr. Ting, I hope all is well. Please find attached a press release draft. The purpose of the press is to not only describe your work but to promote Jeffrey's foundation (hence the title heading and blurb on Jeffrey etc). I understand that the goal of your research is to identify those at higher risk for metastasis-- but could you clarify what the goal of identification is? Is it to improve vigilance and early surgery? Is it also to develop a systemic approach to remedy the biomarkers evident in the enviroment? I have highlighted the research's goals in yellow and hope that you can clarify this for me. I look forward to your adjustments and any edits you see fit. My best regards, www.jeffreyepstein.org<http://wn.jeffreyepstein.org><http://www.jeffreyepstein.org><http://w ww.jeffrcyepstein.org> <Dr. Ting.docx> EFTA_R1_00507258 EFTA02007382 wwwjeffreyepstein.org<tinp://wwwjeffreycpstein.org><http://wwwjeffreyepstein.org> <Dr. Ting.docx> wwwjeffreyepstein.ortchnp-//www.jeffrevepstein org> IM=M www.jeffreyepstein.orq EFTA_R1_00507259 EFTA02007383